This compound is a complex macrolide-class active pharmaceutical ingredient (API) used in pharmaceutical manufacturing and supply chains. Its structure contains multiple rings, ether groups, and stereocenters, consistent with a high-molecular-weight natural product derivative.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 11011-38-4
Pimecrolimus
active pharmaceutical ingredient
8-Epitacrolimus
pharmaceutical raw material
Tacrolimus
pharmaceutical raw material
Tacrolimus hydrate
pharmaceutical raw material
Petrolite E 2020
pharmaceutical raw material
Temocapril hydrochloride
pharmaceutical raw material
Amrubicin
pharmaceutical raw material
Menaquinone
pharmaceutical raw material
17-ethyl-1,14-dihydroxy-12-[1-(4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone
ZDQSOHOQTUFQEM-UHFFFAOYSA-N
CCC1C=C(CC(CC(C2C(CC(C(O2)(C(=O)C(=O)N3CCCCC3C(=O)OC(C(C(CC1=O)O)C)C(=CC4CCC(C(C4)OC)O)C)O)C)OC)OC)C)C
—